In Washington, it was the changing of the guard but not in a way we've ever seen before.
One president departed and another took the oath of office amidst one of the most challenging times in U.S. history; CBS2's Dick Brennan reports.
United States: FDA's Biologics Inspections In The (Negative) Limelight: Will Congress Or Executive Leadership Take Action? - Mintz
In an unexpected twist to a troubling situation that began over two years ago, U.S. Special Counsel Henry Kerner penned a letter to..
Mondaq